Related Experiment Video
Updated: Aug 9, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production
C G Larsen1, M Kristensen, K Paludan
1Department of Dermatology, Marselisborg University Hospital, Aarhus, Denmark.
Insights
1,25(OH)2-D3, a vitamin D hormone, effectively inhibits Interleukin-8 (IL-8) production and gene expression in key inflammatory cells. This suggests a potential therapeutic role for vitamin D in managing inflammatory conditions.
Area of Science:
- Immunology
- Endocrinology
- Dermatology
Background:
- Interleukin-8 (IL-8) is a critical cytokine involved in inflammation, produced by various cells including keratinocytes, fibroblasts, monocytes, and endothelial cells.
- IL-8's role in inflammation makes it a significant therapeutic target for managing inflammatory diseases.
Purpose of the Study:
- To investigate the effect of 1,25(OH)2-cholecalciferol (1,25(OH)2-D3), an endogenous immune modulator, on Interleukin-1 (IL-1)-induced Interleukin-8 (IL-8) production.
- To determine if 1,25(OH)2-D3 can modulate IL-8 production and gene expression in different cell types.
Main Methods:
- Cultured keratinocytes, fibroblasts, peripheral blood monocytes (PBMC), and endothelial cells were stimulated with IL-1 alpha.
- The effect of varying concentrations of 1,25(OH)2-D3 on IL-8 production and mRNA expression was measured.
Main Results:
- 1,25(OH)2-D3 significantly inhibited IL-1 alpha-induced IL-8 production and mRNA expression in keratinocytes, fibroblasts, and PBMC.
- No significant inhibition of IL-8 production was observed in endothelial cells treated with 1,25(OH)2-D3.
- Optimal inhibitory concentrations of 1,25(OH)2-D3 ranged from 10(-10) to 10(-11) M.
Conclusions:
- 1,25(OH)2-D3 demonstrates a regulatory role in controlling chemotactic cytokine production, specifically IL-8.
- The findings suggest a potential therapeutic application for 1,25(OH)2-D3 in conditions characterized by excessive IL-8-mediated inflammation.
Abstract:
Interleukin 8 (IL-8) is a potent leukocyte chemotactic and activating cytokine produced by keratinocytes, fibroblasts, peripheral blood monocytes (PBMC) and endothelial cells. IL-8 is believed to play an important role in the development of inflammation and is thus an obvious target for therapeutical modulation. We studied the possible effect of an endogenous immune modulator 1,25(OH)2-cholecalciferol (1,25(OH)2-D3) on the IL-1-induced IL-8-production by several types of cells. 1,25(OH)2-D3 inhibited the IL-1-alpha induced IL-8 production and mRNA expression in keratinocytes, fibroblasts and PBMC, but not in endothelial cells. Optimal vitamin concentrations varied between 10(-10) and 10(-11) M. These results suggest a potential role of this hormone in the regulation of chemotactic cytokine production.
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
IP3/DAG Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease

